Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Megumi, Umehara"'
Autor:
Kenichi Nakashiki, Yoshimune Sakaki, Mitsuhiro Suenaga, Chuwa Tei, Akihiko Yamaguchi, Susumu Itakura, Megumi Umehara, Masaaki Miyata
Publikováno v:
Journal of Cardiology. 51:106-113
Repeated Waon therapy, which uses a far infrared-ray dry sauna system, improved the vascular endothelial function and the cardiac function in patients with chronic heart failure. In patients with chronic obstructive pulmonary disease (COPD), pulmonar
Autor:
Megumi Umehara, Yuichi Tokito, Yoshimune Sakaki, Takeshi Yoshiyama, Chuwa Tei, Hideo Ohtsubo, Akihiko Yamaguchi, Naomichi Arima, Kosei Arimura, Nakaaki Kawamata, Kenji Terashi, Hiroyasu Mori
Publikováno v:
Experimental Hematology. 30:340-345
Objective We examined the significance of human T-cell lymphotropic virus type I (HTLV-I) Tax protein-induced resistance to anticancer drugs and the relationship between Tax and multidrug resistance proteins. Materials and Methods. S1T cell, a leukem
Autor:
Mitsuhiro, Suenaga, Akihiko, Yamaguchi, Hiroshi, Soda, Koji, Orihara, Yuichi, Tokito, Yoshimune, Sakaki, Megumi, Umehara, Kenji, Terashi, Nakaaki, Kawamata, Mikio, Oka, Shigeru, Kohno, Chuwa, Tei
Publikováno v:
Anticancer research. 26(5A)
Gefitinib (Iressa, ZD1839) is a selective epidermal growth factor receptor tyrosine kinase inhibitor. E2F-1 is a critical determinant in cell cycle. Growth signals up-regulate telomerase activity. The effects of gefitinib on E2F-1 and telomerase in A